| about us | contact us | links | sitemap |
 |
||||||||||||||||
| home | forum | studies | brain games | ||||||||||||||||
 |
||||||||||||||||
|
5-HTP
|
Acetyl L-Carnitine
|
Alpha GPC |
Alpha Lipoic Acid
| Aniracetam
|
Ashwagandha | Centrophenoxine |
||||||||||||||||
  |
Christina P. Lynn-Bullock, Kristy Welshhans, Sarah L. Pallas and Paul S. Katz Department of Biology, MSC 8L0389, Georgia State University, 33 Gilmer St SE Unit 8, Atlanta, GA 30303-3088, USA Received 23 May 2003; Revised 24 November 2003; accepted 2 February 2004. Available online 12 April 2004.
Abstract
5-Hydroxytryptophan (5-HTP), which is the rate-limiting precursor in serotonin (5-hydroxytryptamine (5-HT)) biosynthesis, is used as an oral supplement to enhance serotonin levels in humans. To evaluate its effects on serotonin levels and localization, 5-hydroxytryptophan was administered to Sprague–Dawley rats either orally or via intraperitoneal injection. 5-Hydroxytryptophan-immunoreactivity was co-localized with serotonin-immunoreactivity in the serotonergic dorsal raphe nucleus of control animals and this was not changed in animals given 5-hydroxytryptophan. Oral 5-HTP administration increased the intensity of both 5-HTP and serotonin immunoreactivity in raphe neurons. However, 5-HTP treatment also caused ectopic 5-hydroxytryptophan-immunoreactivity and serotonin-immunoreactivity in normally dopaminergic neurons of the substantia nigra par compacta. Serotonin-immunoreactivity was confined to neurons that also displayed amino acid decarboxylase immunoreactivity, but in a small percentage of substantia nigra neurons, serotonin immunoreactivity was not co-localized with tyrosine hydroxylase-immunoreactivity. The intensity of the immunoreactivity to serotonin and 5-hydroxytryptophan in the substantia nigra was maximal within 2 h of 5-hydroxytryptophan administration and returned to control levels by 24 h. This time course mirrored changes in HPLC measurements of 5-hydroxytryptophan, serotonin, and the metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the urine. 5-Hydroxytryptophan administration did not cause ectopic appearance of either serotonin or 5-hydroxytryptophan in the noradrenergic locus coeruleus. These results suggest that a single oral dose of 5-HTP increases the 5-HTP and serotonin content of serotonergic neurons and causes the transient ectopic appearance of serotonin in some normally non-serotonergic neurons. Author Keywords:
Double label immunohistochemistry; Confocal
fluorescence microscopy; Co-localization; Serotonin;
5-Hydroxytryptophan; HPLC
Corresponding author. Tel.:
+1-404-651-0922; fax: +1-404-651-2509.
|
  |
||||||||||||||
 |
||||||||||||||||
